Using the Oncomine Power Tools, we determined the frequency of BRF2 of overexpression to be highest in breast cancers (2.0%) as compared to lung (1.1%) cancer (Fig. 2a) where BRF2 has been identified as a novel lineage-specific oncogene in lung squamous cell carcinoma [32]. Here, BRF2 is linked to breast carcinoma.